1. Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis
    Tomohisa Sakai et al, 2017, Diagnostic Pathology CrossRef
  2. Less-invasive fascia-preserving surgery for abdominal wall desmoid
    Yoshihiro Nishida et al, 2021, Scientific Reports CrossRef
  3. Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial
    Yoshihiro Nishida et al, 2020, Cancer Science CrossRef
  4. Clinical features and treatment outcome of desmoid-type fibromatosis: based on a bone and soft tissue tumor registry in Japan
    Yoshihiro Nishida et al, 2019, International Journal of Clinical Oncology CrossRef
  5. The Landmark Series: Desmoid
    Marco Fiore et al, 2021, Annals of Surgical Oncology CrossRef
  6. Prognostic significance of CTNNB1 mutation in recurrence of sporadic desmoid tumors
    Lifang Guo et al, 2021, Future Oncology CrossRef
  7. The Prognostic Role of β-Catenin Mutations in Desmoid-type Fibromatosis Undergoing Resection Only
    Milea J. M. Timbergen et al, 2021, Annals of Surgery CrossRef
  8. Risk factors of local recurrence after surgery in extraabdominal desmoid‐type fibromatosis: A multicenter study in Japan
    Yoshihiro Nishida et al, 2020, Cancer Science CrossRef